XTLB Stock Analysis: Buy, Sell, or Hold?
XTLB - XTL Biopharmaceuticals Ltd. American Depositary Shares
$0.85
0.01 (1.73%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Dec 29, 2025
0d
Get Alerted When XTLB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: XTLB is down 19.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: XTLB is down 19.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: XTLB is currently trading at $0.85, which is considered fair relative to its 30-day fair value range of $0.67 to $0.97.
Technical Outlook: Technically, XTLB is in a downtrend. Immediate support is located at $0.80, while resistance sits at $1.11.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+3423.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XTLB is in a downtrend. Immediate support is located at $0.80, while resistance sits at $1.11.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+3423.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.67 -
$0.97
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Protect Your Profits
Holding XTLB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 3423.2% below Wall St target ($30.00)
- WARNING: Recommendation downgraded due to -19.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.67 -
$0.97
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.80
Resistance Level
$1.11
Current Trend
Downtrend
Fundamental Context
Wall Street Target
$30.00
(+3423.2%)
Earnings Growth (YoY)
-76.0%
Last updated: February 01, 2026 2:42 AM ET
Data refreshes hourly during market hours. Next update: 3:42 AM
Data refreshes hourly during market hours. Next update: 3:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XTLB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced XTLB Option Strategies
Professional options setups generated by AI based on today's XTLB price and gamma walls.